Projects per year
Personal profile
External positions
Co-founder and CSO, Lava Therapeutics, Utrecht, The Netherlands
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
Targeting of CD1d in multiple myeloma
van der Vliet, J. (Principal investigator)
01/01/2014 → 31/12/2016
Project: Research
-
Reintroduction of palliative intent FOLFIRINOX chemotherapy in a real world pancreatic cancer cohort
van Zweeden, A. A., van der Geest, L. G. M., Pijnappel, E. N., de Vos-Geelen, J., van Hooft, J. E., Stommel, M. W. J., de Wit, G. F., Verheul, H. M. W., van Laarhoven, H. W. M. & the Dutch Pancreatic Cancer Group, 2025, (E-pub ahead of print) In: Pancreatology.Research output: Contribution to journal › Article › Academic › peer-review
-
Allogeneic NK cells induce the in vitro activation of monocyte-derived and conventional type-2 dendritic cells and trigger an inflammatory response under cancer-associated conditions
Toffoli, E. C., van Vliet, A. A., Forbes, C., Arns, A. J., Verheul, H. W. M., Tuynman, J., van der Vliet, H. J., Spanholtz, J. & de Gruijl, T. D., 1 May 2024, In: Clinical and experimental immunology. 216, 2, p. 159-171 13 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access1 Citation (Scopus) -
Exploring immune status in peripheral blood and tumor tissue in association with survival in patients with multi-organ metastatic colorectal cancer
Bakkerus, L., Subtil, B., Bontkes, H. J., Gootjes, E. C., Reijm, M., Vullings, M., Verrijp, K., Bokhorst, J.-M., Woortman, C., Nagtegaal, I. D., Jonker, M. A., van der Vliet, H. J., Verhoef, C., Gorris, M. A. J., de Vries, I. J. M., de Gruijl, T. D., Verheul, H. M. W., Buffart, T. E. & Tauriello, D. V. F., 2024, In: Oncoimmunology. 13, 1, p. 2361971 2361971.Research output: Contribution to journal › Article › Academic › peer-review
Open Access2 Citations (Scopus) -
Leveraging Vγ9Vδ2 T cells against prostate cancer through a VHH-based PSMA-Vδ2 bispecific T cell engager
King, L. A., Veth, M., Iglesias-Guimarais, V., Blijdorp, I., Kloosterman, J., Vis, A. N., Roovers, R. C., Hulsik, D. L., Riedl, T., Adang, A. E. P., Parren, P. W. H. I., van Helden, P. M., de Gruijl, T. D. & van der Vliet, H. J., 20 Dec 2024, In: iScience. 27, 12, 111289.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Vaccination with DC-SIGN-Targeting αGC Liposomes Leads to Tumor Control, Irrespective of Suboptimally Activated T-Cells
de Haas, A. M., Stolk, D. A., Schetters, S. T. T., Goossens-Kruijssen, L., Keuning, E., Ambrosini, M., Boon, L., Kalay, H., Storm, G., van der Vliet, H. J., de Gruijl, T. D. & van Kooyk, Y., 1 May 2024, In: Pharmaceutics. 16, 5, 581.Research output: Contribution to journal › Article › Academic › peer-review
Open Access